Raily Aesmed (02135) announced its full-year financial results for the fiscal year ended December 31, 2025. The group recorded revenue of 189 million yuan, representing a decrease of 4.98% compared to the previous year. Profit attributable to shareholders was 1.87 million yuan, marking a turnaround from a loss in the same period last year. Earnings per share were 0.34 cents.